Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05742646
Other study ID # 00109618
Secondary ID 5P20NR016575-04
Status Completed
Phase N/A
First received
Last updated
Start date January 12, 2022
Est. completion date April 29, 2022

Study information

Verified date December 2023
Source Medical University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this 4 week pilot study is to test the use of a mobile application (also commonly referred to as an app) designed to help increase self-management strategies among youth that have asthma and obesity. The data obtained from this study will facilitate refinement of the app and interventional approaches for a future larger scale study to increase youth self-management of their clinical conditions, symptom management, and health maintenance as they transition to adulthood.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date April 29, 2022
Est. primary completion date April 29, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 10 Years and older
Eligibility Inclusion Criteria: - Youth-Caregiver Dyad Inclusion Criteria: - Male and female youth aged 10 - 17 years - Adult primary caregiver (18 years and older) - English speaking - Youth diagnosis of asthma - Prescribed inhaler treatment for asthma - Youth Body Mass Index at or above the 85th percentile for age and sex based on the Centers for Disease Control (CDC) growth charts - Must own a smartphone (iOS) with working Wi-Fi access and/or cellular data plan - Prescribed inhaler treatment for asthma Exclusion Criteria: - Diagnosis of cognitive impairment - Inability or unwillingness of youth participant to assent and/or primary caregiver/legal guardian/representative to give informed consent - Inability or unwillingness to participate in the audio recording interview session or complete study procedures

Study Design


Intervention

Behavioral:
MATADORS
Youth will have access to the MATADORS app to include basic information and expanded educational features. They will be asked to log into the app daily for one month and they will be asked to report within the app how they are feeling each day and their medications taken.
MATADORS Control
Youth will have access to the MATADORS app basic information. They will be asked to log into the app daily for one month and they will be asked to report within the app their medications taken.

Locations

Country Name City State
United States Medical University of South Carolina Charleston South Carolina

Sponsors (3)

Lead Sponsor Collaborator
Medical University of South Carolina National Institute of Nursing Research (NINR), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants completing 4-week study period Participant retention and feasibility in completing the 4-week study 4-week study period
Secondary Loss to follow-up Number of participants lost to follow-up 8 weeks
Secondary Study withdrawals Number of participants who self withdrew from the study 8 weeks
Secondary End of study dyadic interviews Number of completed end of study dyadic interviews 8 weeks
Secondary Change in Fatigue Change in Fatigue (measured by PROMIS Pediatric Fatigue)-Self-report of fatigue symptoms ranging from tiredness to overwhelming exhaustion. Low score indicates a low level of fatigue and a high score may represent extreme or debilitating levels of exhaustion 8 weeks
Secondary Change in Self-Efficacy Change in Self-Efficacy (measured by Change in Self-Efficacy for Managing Chronic Disease-6 item scale). This is a 6-item instrument reported on an analog scale that highlights one's confidence in managing their chronic disease. Each item ranges from 1 (not confident at all) to 10 (extremely confident). The higher the total score indicates the higher the level of self-efficacy. 8 weeks
Secondary Change in Asthma Control Change in asthma control (measured by Asthma Control Test). Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score >19 indicates well-controlled asthma. 8 weeks
Secondary Physical Activity Patterns Number of minutes active per day Daily for 28 days
Secondary Medication adherence Self-report of rescue and/or controller medication usage Daily for 28 days
Secondary Symptom reporting Number of days reporting symptoms of fatigue, pain, anxiety, depression Daily for 28 days
Secondary Missed school/work/activity Self-report of the number of days where the participant missed school, work, or activities Baseline, week 4, and week 8
Secondary Activity tracker-step count Number of steps taken per day based reported through activity tracker Daily for 28 days
Secondary Sleep patterns Number of hours of sleep per day as reported through activity tracker Daily for 28 days
Secondary Inability to concentrate Self-report on inability to concentrate Daily for 28 days
Secondary Daytime sleepiness Self-report of daytime sleepiness Daily for 28 days
Secondary Asthma Belief Survey The instrument is a 15-item tool that uses a 5-point self-report scale to measure asthma self-efficacy in relation to daily asthma maintenance and an asthma crisis. A rating of 1 = little confidence whereas a rating of 5 = a high confidence level. Responses are averaged across items to indicate an overall score ranging between 1 (low confidence) to 5 (high confidence) Baseline, week 4, and week 8
Secondary Short Assessment of Health Literacy-English 18-item instrument to assess the ability to read and understand common medical terms. A score between 0 and 14 suggests the examinee has low health literacy. Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2